XML 34 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCKHOLDERS’ EQUITY (Tables)
6 Months Ended
Jun. 30, 2017
Stockholders' Equity Note [Abstract]  
Summary Of Number Of Price-Reduced and Price-Retained Warrants
Additionally, the exercise prices for certain investors of Series C, Series D and Series F warrants were reduced as follows:
 
Series
 
Number of Warrant Shares Repriced
 
Pre-reduced Price
 
Post-reduced Price
 
Series C
 
 
313,750
 
$
6.00
 
$
4.00
 
Series D
 
 
312,500
 
$
9.00
 
$
4.00
 
Series F
 
 
292,500
 
$
7.20
 
$
4.00
 
Valuation Methodology
A weighted average summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company’s common stock purchase warrants that are included in the modification is as follows:
 
 
 
Weighted Average Inputs
 
 
 
Before Modification
 
 
After Modification
 
Exercise price
 
$
8.32
 
 
$
4.04
 
Contractual term (years)
 
 
3.34
 
 
 
3.34
 
Volatility (annual)
 
 
200
%
 
 
200
%
Risk-free rate
 
 
1.50
%
 
 
1.50
%
Dividend yield (per share)
 
 
0.00
%
 
 
0.00
%